According to Supernus Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 2.72403.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 2.04 | 18.81% |
2023-12-31 | 1.72 | -21.15% |
2022-12-31 | 2.18 | 14.47% |
2021-12-31 | 1.90 | 6.44% |
2020-12-31 | 1.79 | -14.67% |
2019-12-31 | 2.09 | -45.45% |
2018-12-31 | 3.84 | -49.77% |
2017-12-31 | 7.64 | 17.08% |
2016-12-31 | 6.52 | -12.83% |
2015-12-31 | 7.48 | -14.61% |
2014-12-31 | 8.76 | -2.72% |
2013-12-31 | 9.01 | 136.22% |
2012-12-31 | 3.81 | |
2011-12-31 | N/A | |
2010-12-31 | N/A | |
2009-12-31 | N/A |